23 June 2014
Last updated at 16:09
Shire Pharmaceuticals is known primarily as a maker of drugs to treat rare diseases
UK drugs firm Shire has said it expects to double its current product sales to $10bn by 2020 as it tries to fend off a $46bn (£27bn) bid from US rival AbbVie.
...
Shire forecasts $10bn sales by 2020
Monday, June 23, 2014
Shire forecasts $10bn sales by 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment